Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Cancer immunotherapy")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 178

  • Page / 8
Export

Selection :

  • and

DNA immunization with plasmids expressing hCGβ-chimerasTERRAZZINI, Nadia; HANNESDOTTIR, Solveig; DELVES, Peter J et al.Vaccine. 2004, Vol 22, Num 17-18, pp 2146-2153, issn 0264-410X, 8 p.Article

Immune surveillance and immunotherapy: Lessons from carbohydrate mimotopesPASHOV, Anastas; MONZAVI-KARBASSI, Behjatolah; KIEBER-EMMONS, Thomas et al.Vaccine. 2009, Vol 27, Num 25-26, pp 3405-3415, issn 0264-410X, 11 p.Conference Paper

CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccinationCHENG, W. F; HUNG, C. F; LIN, K. Y et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 16, pp 1311-1320, issn 0969-7128, 10 p.Article

A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibodyHARDY, Britta; RAITER, Annat.Vaccine. 2005, Vol 23, Num 34, pp 4283-4291, issn 0264-410X, 9 p.Article

Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopesTINE, John A; FIRAT, Huseyin; PAYNE, Anne et al.Vaccine. 2005, Vol 23, Num 8, pp 1085-1091, issn 0264-410X, 7 p.Article

Virus-based immunotherapy of cancer: what do we know and where are we going? : Review articleSORENSEN, Maria Rathmann; THOMSEN, Allan Randrup.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2007, Vol 115, Num 11, pp 1177-1193, issn 0903-4641, 17 p.Article

Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironmentSHAHAR, Ehud; GORODETSKY, Raphael; GABERMAN, Elena et al.Vaccine. 2010, Vol 28, Num 45, pp 7279-7287, issn 0264-410X, 9 p.Article

Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapyEFFROS, Rita B.Cancer immunology and immunotherapy. 2004, Vol 53, Num 10, pp 925-933, issn 0340-7004, 9 p.Article

Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancerFRANSEN, Marieke F; CORDFUNKE, Robert A; SLUIJTER, Marjolein et al.Vaccine. 2014, Vol 32, Num 15, pp 1654-1660, issn 0264-410X, 7 p.Article

Preparation and anti-tumor evaluation of polyactin A microparticles from supercritical CO2 processingJIANHONG BI; JINGLAN ZHAO; LANG BAO et al.Applied surface science. 2008, Vol 255, Num 2, pp 320-323, issn 0169-4332, 4 p.Conference Paper

Lessons from randomized phase III studies with active cancer immunotherapies -Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)FINKE, Lothar H; WENTWORTH, Kerry; BLUMENSTEIN, Brent et al.Vaccine. Supplement. 2007, Vol 25, Num 2, issn 1359-5938, B97-B109Article

Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapyZHEN HUANG; ZHENGPING ZHANG; YUCUI JIANG et al.Journal of controlled release. 2012, Vol 158, Num 2, pp 286-292, issn 0168-3659, 7 p.Article

Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapyKIGASAWA, Kaoru; KAJIMOTO, Kazuaki; NAKAMURA, Takashi et al.Journal of controlled release. 2011, Vol 150, Num 3, pp 256-265, issn 0168-3659, 10 p.Article

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroRAY, Swagatam; CHHABRA, Arvind; ECONOMOU, James S et al.Clinical immunology (Orlando, Fla. Print). 2010, Vol 136, Num 3, pp 338-347, issn 1521-6616, 10 p.Article

Neuroimmunomodulation in Medical Oncology : Application of Psychoneuroimmunology with Subcutaneous Low-dose IL-2 and the Pineal Hormone Melatonin in Patients with Untreatable Metastatic Solid TumorsLISSONI, Paolo; BRIVIO, Fernando; FUMAGALLI, Luca et al.Anticancer research. 2008, Vol 28, Num 2B, pp 1377-1381, issn 0250-7005, 5 p.Article

Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cellQIANLI WANG; JUNPING ZHANG; ZHONGWU GUO et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 24, pp 7561-7567, issn 0968-0896, 7 p.Article

Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomasCHO, Hyun-Il; YOUNG SEON HONG; MYUNG AH LEE et al.International journal of hematology. 2006, Vol 83, Num 1, pp 66-73, issn 0925-5710, 8 p.Article

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant : therapeutic activity against human cervical cancer in a rodent modelZHENGRONG CUI; FU QIU.Cancer immunology and immunotherapy. 2006, Vol 55, Num 10, pp 1267-1279, issn 0340-7004, 13 p.Article

Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulinILSIEH, Chia-Jung; TAE WOO KIM; HUNG, Chien-Fu et al.Vaccine. 2004, Vol 22, Num 29-30, pp 3993-4001, issn 0264-410X, 9 p.Article

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residuesTSUBOI, Akihiro; OKA, Yoshihiro; KAWAKAMI, Manabu et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 11-12, pp 614-620, issn 0340-7004, 7 p.Article

Cancer Immunotherapy by Intratumoral Injection of α-gal GlycolipidsWHALEN, Giles F; SULLIVAN, Mary; PIPERDI, Bilal et al.Anticancer research. 2012, Vol 32, Num 9, pp 3861-3868, issn 0250-7005, 8 p.Article

Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cellsXUEWEN DENG; TERUNUMA, Hiroshi; NIEDA, Mie et al.International immunopharmacology (Print). 2012, Vol 14, Num 4, pp 593-605, issn 1567-5769, 13 p.Article

Genetic engineering with T cell receptorsLING ZHANG; MORGAN, Richard A.Advanced drug delivery reviews. 2012, Vol 64, Num 8, pp 756-762, issn 0169-409X, 7 p.Article

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinomaKOBAYASHI, Hirohito; TANAKA, Yoshimasa; YAGI, Junji et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 8, pp 1075-1084, issn 0340-7004, 10 p.Article

The mechanisms of cancer immunoescape and development of overcoming strategies : PIH: Cancer immunologyYAGUCHI, Tomonori; SUMIMOTO, Hidetoshi; KUDO-SAITO, Chie et al.International journal of hematology. 2011, Vol 93, Num 3, pp 294-300, issn 0925-5710, 7 p.Article

  • Page / 8